1. Home
  2. YHC vs AIDX Comparison

YHC vs AIDX Comparison

Compare YHC & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$0.80

Market Cap

19.2M

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.60

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
AIDX
Founded
2021
N/A
Country
United States
United States
Employees
4
N/A
Industry
Beverages (Production/Distribution)
Precision Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
19.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YHC
AIDX
Price
$0.80
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.7K
56.6K
Earning Date
04-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$1.45
52 Week High
$11.14
$14.09

Technical Indicators

Market Signals
Indicator
YHC
AIDX
Relative Strength Index (RSI) 41.79 23.81
Support Level $0.79 $1.51
Resistance Level $0.94 $2.08
Average True Range (ATR) 0.06 0.13
MACD -0.01 0.10
Stochastic Oscillator 33.61 37.50

Price Performance

Historical Comparison
YHC
AIDX

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: